Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic : Journal of Pediatric Hematology/Oncology

Secondary Logo

Journal Logo

Online Articles: Clinical and Laboratory Observations

Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic

Noisette, M. Laurence MD*; Phillips, Shannon RN, PhD; Schlenz, Alyssa M. PhD; Mueller, Martina PhD†,§; Kanter, Julie MD

Author Information
Journal of Pediatric Hematology/Oncology 43(8):p e1231-e1234, November 2021. | DOI: 10.1097/MPH.0000000000002008

Abstract

Background: 

Specialty care for children with sickle cell disease (SCD) may be disrupted during the coronavirus (COVID-19) pandemic. Our DISPLACE consortium includes 28 pediatric SCD centers.

Methods: 

In May 2020, we surveyed the consortium on the impact of COVID-19 on their practice focusing on transcranial Doppler ultrasound, chronic red cell transfusions, telehealth, and COVID-19 testing.

Observation: 

Twenty-four DISPLACE providers completed the survey. Transcranial Doppler ultrasound screening decreased to 67% but chronic red cell transfusions remained at 96%. Most investigators (92%) used telehealth and 40% of providers had patients test positive for COVID-19.

Conclusion: 

The COVID-19 pandemic has affected routine care and necessitated changes in practice in SCD.

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid